ZR2 Bioenergy Limited (BOM:506640)
119.55
+0.70 (0.59%)
At close: Aug 21, 2026
ZR2 Bioenergy Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 1,903 | 1,567 | 999 | 283 | 80 | 72 | |
Market Cap Growth | 38.36% | 56.83% | 252.51% | 253.75% | 11.81% | 285.63% |
Enterprise Value | 1,715 | 1,382 | 401 | 270 | 75 | 70 |
Last Close Price | 119.55 | 98.45 | 279.93 | 79.41 | 49.49 | 44.26 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 116.62 | 156.05 | 1107.85 | 72.84 | 223.76 | 18.28 |
PS Ratio | - | - | 65.98 | 18.01 | - | 6.20 |
PB Ratio | 1.36 | 1.12 | 0.72 | 1.68 | 1.83 | 1.65 |
P/TBV Ratio | 1.36 | 1.12 | 0.72 | 1.68 | 1.83 | 1.65 |
P/FCF Ratio | - | - | - | - | - | 7.92 |
P/OCF Ratio | - | - | 3.22 | - | - | 7.92 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | - | - | 26.49 | 17.19 | - | 6.04 |
EV/EBITDA Ratio | - | - | - | 233.18 | - | 145.46 |
EV/EBIT Ratio | - | - | - | 236.10 | - | 154.77 |
EV/FCF Ratio | - | - | - | - | - | 7.71 |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | - | - | - | 1.31 | 2.75 | - |
Debt / EBITDA Ratio | - | - | - | 189.74 | - | - |
Net Debt / Equity Ratio | -0.13 | -0.13 | -0.14 | 1.05 | 2.67 | -0.31 |
Net Debt / EBITDA Ratio | 26.14 | 27.66 | 72.71 | 152.58 | -120.26 | -27.79 |
Net Debt / FCF Ratio | - | 9.80 | 0.22 | -0.88 | -1.03 | -1.47 |
Asset Turnover | - | - | 0.02 | 0.06 | - | 0.27 |
Quick Ratio | - | 15.02 | 124.49 | 17.58 | 14.38 | 11.64 |
Current Ratio | - | 15.45 | 126.65 | 104.33 | 355.72 | 12.04 |
Return on Equity (ROE) | - | 0.72% | 0.11% | 3.67% | 0.82% | 9.45% |
Return on Assets (ROA) | - | -0.40% | -0.21% | 0.26% | -0.59% | 0.65% |
Return on Invested Capital (ROIC) | -0.80% | -0.74% | -0.18% | 0.45% | -1.04% | 1.34% |
Return on Capital Employed (ROCE) | - | -0.60% | -0.20% | 0.30% | -0.60% | 1.00% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | 0.48% | 0.64% | 0.09% | 1.37% | 0.45% | 5.47% |
FCF Yield | -1.01% | -1.23% | -88.50% | -71.23% | -141.58% | 12.63% |
Dividend Yield | 0.08% | - | 0.04% | - | - | - |
Payout Ratio | - | 3.55% | - | - | - | - |
Buyback Yield / Dilution | 83.73% | 61.90% | -1231.40% | -94.13% | - | - |
Total Shareholder Return | 83.81% | 61.90% | -1231.37% | -94.13% | - | - |